22nd Century Group News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.10.18	FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast (Businesswire)
05.09.18	JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes (Businesswire)
21.08.18	22nd Century Receives Order for 3.6 Million SPECTRUM® U.S. Government Research Cigarettes (Businesswire)
07.08.18	22nd Century Files 2018 Second Quarter Report (Businesswire)
31.07.18	Washington Examiner Publishes Public Policy Article by 22nd Century’s James Vail and Juan Sanchez Tamburrino, Ph.D. (Businesswire)
24.07.18	Nondaily Smokers Who Switch to 22nd Century’s Very Low Nicotine Content Cigarettes Reduce their Consumption by a Staggering 51% (Businesswire)
17.07.18	22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan (Businesswire)
11.07.18	22nd Century Reports on New Responses to the FDA’s Nicotine Reduction Plan (Businesswire)
03.07.18	22nd Century Highlights Public Comments to the FDA’s Nicotine Reduction Plan (Businesswire)
26.06.18	22nd Century kündet neue heissluftgetrocknete, nikotinarme und Burley-Tabaksorten ohne GMO an (Businesswire)
26.06.18	22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties (Businesswire)
25.06.18	22nd Century Group Added to Russell 2000, Russell 3000 and Russell Global Indexes (Businesswire)
20.06.18	22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA (Businesswire)
13.06.18	22nd Century Group to be Added to Russell 2000, Russell 3000, and Russell Global Indexes (Businesswire)
04.06.18	22nd Century to Present to Institutional Investors at the Citi 2018 Small & Mid Cap Conference (Businesswire)
29.05.18	Altria, Reynolds, Lorillard, and Philip Morris Ordered to Issue Corrective Statements on Nicotine Addiction; 22nd Century’s Proprietary VLN (TM) Tobacco Called "Minimally or Non-Addictive” (Businesswire)
24.05.18	Public Health Leaders Urge FDA to Issue Final Rule for Reducing Nicotine in Cigarettes by March 2019 (Businesswire)
03.05.18	22nd Century Files 2018 First Quarter Report (Businesswire)
25.04.18	22nd Century Committed to Advancing FDA’s Nicotine Mandate (Businesswire)
23.04.18	Food and Drug Law Institute Publishes Public Policy Article by 22nd Century’s Dr. James Swauger (Businesswire)
19.03.18	FDA Publishes Advance Notice of Proposed Rulemaking (ANPRM) on Lowering Nicotine in Cigarettes (Businesswire)
06.03.18	17th World Conference on Tobacco or Health Will Feature Discussion on the FDA’s Plan to Dramatically Reduce Nicotine in Cigarettes (Businesswire)
22.02.18	22nd Century Group to Present International Survey Findings at the Society for Research on Nicotine and Tobacco Annual Meeting (Businesswire)
01.02.18	22nd Century to Present at BIO CEO & Investor Conference (Businesswire)
04.12.17	22nd Century Hires Former BAT Head of Plant Biotechnology (Businesswire)
30.11.17	22nd Century Ships 2.4 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse (Businesswire)
22.11.17	Anticipating FDA’s "Reduced Nicotine Mandate,” 22nd Century Will Discontinue U.S. Sales of RED SUN Brand (Businesswire)
09.11.17	22nd Century Group Files 2017 Third Quarter Report and Announces Conference Call to Provide Business Update (Businesswire)
02.11.17	22nd Century Hires Former Reynolds American Vice President (Businesswire)
06.10.17	Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm (Businesswire)
25.09.17	22nd Century von restriktivem Lizenzvertrag mit British American Tobacco befreit (Businesswire)
19.09.17	Global Legal Cannabis Sales Projected to Grow (PR Newswire)
13.09.17	Cannabis Industry Becoming one of the Fastest Growing Sectors With Infusion of Innovative Services and Technology Advancements (PR Newswire)
13.09.17	Cannabis Industry Becoming one of the Fastest Growing Sectors With Infusion of Innovative Services and Technology Advancements (PR Newswire)
16.08.17	FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators (PR Newswire)
16.08.17	FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
08.08.17	Legal Cannabis and CBD Based Products Continue to Show Robust Growth (PR Newswire)
08.08.17	Legal Cannabis and CBD Based Products Continue to Show Robust Growth (PR Newswire)
26.07.17	How These Biotech Stocks are Performing? -- Intrexon, 22nd Century, Corcept Therapeutics, and Achaogen (PR Newswire)
20.07.17	The Next Gold Rush is Green (PR Newswire)
18.07.17	Where the Smart Money is Looking This Summer (PR Newswire)
22.06.17	Pharmaceutical Advancements in Medicinal Marijuana Continue to Evolve While Producing Higher Quality Cannabinoid Extracts (PR Newswire)
22.06.17	Pharmaceutical Advancements in Medicinal Marijuana Continue to Evolve While Producing Higher Quality Cannabinoid Extracts (PR Newswire)
15.06.17	New International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes (Businesswire)
13.06.17	Legal Cannabis Sales Grow in North America (PR Newswire)
07.06.17	Cannabis Grow Operations and Development of Newest Products Boosting Growth in Hydroponic Supplies Market (PR Newswire)
07.06.17	Cannabis Grow Operations and Development of Newest Products Boosting Growth in Hydroponic Supplies Market (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.04	-0.08 %	K V
Swiss Life Hldg	687.20	-0.26 %	K V
Kuehne+Nagel Int	201.50	-0.40 %	K V
Swiss Re	128.85	-0.58 %	K V
Swisscom	499.80	-0.64 %	K V
Logitech Intl	72.86	-2.62 %	K V
UBS Group	26.83	-3.56 %	K V
Roche Hldg G	245.70	-3.65 %	K V
Part Grp Hldg	1’218.00	-4.21 %	K V
ABB	48.68	-5.51 %	K V

Nachrichten zu 22nd Century Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten